VITOGEN B COMPOUND W C FORTIS CAPSULES 20 MG
D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) : 20 MG ASCORBIC ACID (ASCORBIC ACID) : 300 MG VITAMIN B1 (THIAMINE MONONITRATE) : 35 MG VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) : 5 MG VITAMIN B2 : 15 MG VITAMIN B12 : .01 MG NICOTINAMIDE : 50 MG · DIN 00231770 · STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC.
Health Canada status: CANCELLED POST MARKET
What is VITOGEN B COMPOUND W C FORTIS CAPSULES?
VITOGEN B COMPOUND W C FORTIS CAPSULES 20 MG contains D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) : 20 MG ASCORBIC ACID (ASCORBIC ACID) : 300 MG VITAMIN B1 (THIAMINE MONONITRATE) : 35 MG VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) : 5 MG VITAMIN B2 : 15 MG VITAMIN B12 : .01 MG NICOTINAMIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00231770, held by STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 20-Jul-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00231770 |
|---|---|
| Brand name | VITOGEN B COMPOUND W C FORTIS CAPSULES |
| Generic / active ingredient | D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) : 20 MG ASCORBIC ACID (ASCORBIC ACID) : 300 MG VITAMIN B1 (THIAMINE MONONITRATE) : 35 MG VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) : 5 MG VITAMIN B2 : 15 MG VITAMIN B12 : .01 MG NICOTINAMIDE : 50 MG |
| Manufacturer | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. |
| Strength | 20 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A11EB VITAMIN B-COMPLEX WITH VITAMIN C |
| AHFS class | 88:08.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 20-Jul-2005 |
| Original market date | 1972-12-31 00:00:00 |
Is VITAMIN B-COMPLEX WITH VITAMIN C in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANDOZ CANADA INCORPORATED (Tier 3 Drug Shortages About & Resources), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for VITOGEN B COMPOUND W C FORTIS CAPSULES
What can be used instead?
Other Canadian products sharing ATC code A11EB VITAMIN B-COMPLEX WITH VITAMIN C. 0 of 70 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALLBEE WITH C 550 CAP | 50 MG | CAPSULE | WHITEHALL-ROBINS INC. | CANCELLED POST MARKET | DIN 01932470 |
| ALLBEE WITH VITAMIN C CAP | 10 MG | CAPSULE | WHITEHALL-ROBINS INC. | CANCELLED POST MARKET | DIN 01932489 |
| B C ANTISTRESS CAP | 5 MG | CAPSULE | LES LABORATOIRES BIO-SANTÉ INC. | CANCELLED POST MARKET | DIN 00479039 |
| B COMPLEX 500 TAB | 10 MG | TABLET | NOBEL PHARM ENR. | CANCELLED POST MARKET | DIN 00510424 |
| B COMPLEX PLUS C 300MG TAB | 10 MCG | TABLET | NUTRICORP INTERNATIONAL | CANCELLED POST MARKET | DIN 02022311 |
| B COMPLEX W C FORTE CAP | 15 MG | CAPSULE | EVEREST PHARMACEUTICALS LTD. | CANCELLED POST MARKET | DIN 00515965 |
| B COMPLEX W VITAMIN C FORTIS CAP | 5 MG | CAPSULE | SHOPPERS DRUG MART INC. | CANCELLED POST MARKET | DIN 00414832 |
| B COMPLEX WITH C 300MG | 300 MG | CAPSULE | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | DIN 00557390 |
| B COMPLEX WITH C 300MG TAB | 15 MG | TABLET | PHARMAVITE LLC | CANCELLED POST MARKET | DIN 00723045 |
| B COMPLEX WITH C 550MG | 10 MG | CAPSULE | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | DIN 00557404 |
Who else supplies VITAMIN B-COMPLEX WITH VITAMIN C worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. VITAMIN B-COMPLEX WITH VITAMIN C appears in 130 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.